Dr. Pansick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12200 Park Central Dr
Ste 180
Dallas, TX 75251Phone+1 214-320-8785Fax+1 214-645-2011
Education & Training
- Nassau University Medical CenterResidency, Ophthalmology, 2018 - 2021
- MedStar Health/Georgetown-Washington Hospital CenterInternship, Internal Medicine, 2017 - 2018
- University of Texas Southwestern Medical SchoolClass of 2017
Certifications & Licensure
- TX State Medical License 2021 - 2026
- DC State Medical License 2017 - 2018
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Evaluation of a novel treatment, selenium disulfide, in killing Demodex folliculorum in vitro.Joshua Heczko, Carson Schell, Andrew Pansick, Rebecca Stein, Henry D Perry
Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2023-10-01 - 5 citationsTOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors.B. Cameron Carr, Caitlyn E. Emigh, Lea D Bennett, Andrew D. Pansick, David G. Birch
Retina. 2017-01-01 - 14 citationsUse of Intravenous Vancomycin and Cefepime in Preventing Endophthalmitis After Open Globe InjuryJason M. Huang, Andrew D. Pansick, Preston H. Blomquist
Journal of Ocular Pharmacology and Therapeutics. 2016-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: